Shanghai Fudan Zhangjiang Bio Pharmaceutical Co (HK:1349) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co has subscribed to a structured deposit product with SPD Bank, investing RMB200 million from its own idle funds. The product offers a principal-guaranteed return with a floating rate, linked to EUR/USD exchange rate fluctuations, over a term of 89 days. This transaction is considered a disclosable one under Hong Kong’s listing rules, but does not require shareholder approval.
For further insights into HK:1349 stock, check out TipRanks’ Stock Analysis page.
